Follow The Filings

ORIC Oric Pharmaceuticals

Oric Pharmaceuticals earnings company data as of 4:47 AM ET 10/22

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ORIC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ORIC insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $2.5M sold by 2 insiders under 10b5-1 plans
  1. Dominic Piscitelli CFO
    Planned sale
    $189K 14,000 shares at $13.53 17% of stake
    Traded Oct 20 Filed Oct 21
    ↗
  2. Richard A. Heyman Director
    Planned sale
    $87K 6,700 shares at $12.91
    Traded Oct 1 Filed Oct 2
    ↗
  3. Dominic Piscitelli CFO
    Planned sale
    $181K 13,400 shares at $13.53 16% of stake
    Traded Sep 28 Filed Sep 29
    ↗
  4. Dominic Piscitelli CFO
    Planned sale
    $8,103 600 shares at $13.50 0.9% of stake
    Traded Sep 24 Filed Sep 25
    ↗
  5. Dominic Piscitelli CFO
    Planned sale
    $1.1M 77,000 shares at $13.69 52% of stake
    Traded Aug 26 Filed Aug 28
    ↗
  6. Richard A. Heyman Director
    Planned sale
    $157K 13,100 shares at $12.02
    Traded Jul 24 Filed Jul 28
    ↗
  7. Richard A. Heyman Director
    Planned sale
    $3,600 300 shares at $12.00 0.1% of stake
    Traded Jul 6 Filed Jul 8
    ↗
  8. Dominic Piscitelli CFO
    Planned sale
    $703K 52,000 shares at $13.51 43% of stake
    Traded Feb 24 Filed Feb 26
    ↗
  9. Richard A. Heyman Director
    Planned sale
    $80K 6,700 shares at $12.00
    Traded Jan 16 Filed Jan 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 13 option exercises and 3 sales to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.